Somavert turns twenty: the pegvisomant story
From J D Faccinetti, Co-founder and Chief Editor – When you deal with a chronic pituitary disease, you get close to your medications, just like you would to a friend. This was my experience with
Search Results for: Pegvisomant
On access to Pegvisomant in Chile
Chile’s Acromegaly support group CORAPEHI focuses on access to Pegvisomant in their struggle to improve access to medication for acromegaly patients in that country. Since 2010 Acromegaly Chile and CORAPEHI (Corporation to Help Patients with
Pegvisomant, glucose metabolism, and acromegaly
In this podcasts, we discuss an important recent meta-analysis study from the University of Rome on the relationship between pegvisomant, a drug used for the treatment of acromegaly, and glucose metabolism. Dr. Blevins also dives into
Discussing the rationale for Pegvisomant dose adjustments
Listen to this engaging podcast where PWN cofounders Dr. Blevins and JD Faccinetti discuss the ins and outs of a Somavert (pegvisomant for injection) dose adjustment based on a recent case. . Don’t miss it!
News from Chile and Ecuador
Margarita Vazques de Amoroso, founder, and president of Faeth in Ecuador sent us some information on their monthly meetings. “We try to get together monthly to share our experiences and knowledge about how to
Tulane University study aims to understand acromegaly physician/patient treatment perception gaps
A current study from Tulane University is attempting to study aspects of the management of acromegaly patients and their perceptions of treatment. The study is being conducted by Dr. Lizheng Shi. Dr. Shi has been
Acromegaly (part 3), medical treatment
In this podcast, Dr. Lewis Blevins discusses the medical management of acromegaly with the drug “pegvisomant for injection” or Somavert. This is our third podcast in a series of six on acromegaly and its management.
Acromegaly guidelines: How useful are they?
From Lewis S. Blevins, Jr. MD – Every few years, one organization or another releases “guidelines” and “recommendations” regarding the management of patients with acromegaly. These often include algorithms provided by an “acromegaly consensus group”
Be wary of lofty claims that sound too good to be true
We promote traditional approaches to pituitary disorders. We believe in ongoing research and development to expand knowledge and discover new therapies. We recognize that most medications have, as their point of origin, some derivation from